Phenotype measure:   Jaxpheno6   pct_CD4_8

ID, description, units MPD:23101   pct_CD4_8   splenic CD4 T cells (percentage of total viable cells)   [%]  at age age 8wks
Data set, strains Jaxpheno6   inbred   11 strains     sex: both     age: 8wks
Procedure immune cell quantification
Ontology mappings

  STRAIN COMPARISON PLOT
Dimensions Width:   px    Height:   px
Download Plot   
Visualization Options

Jaxpheno6 - splenic CD4 T cells (percentage of total viable cells) at age age 8wks



  MEASURE SUMMARY
Measure Summary FemaleMale
Number of strains tested11 strains11 strains
Mean of the strain means14.1   % 15.6   %
Median of the strain means15.3   % 15.4   %
SD of the strain means± 6.34 ± 6.82
Coefficient of variation (CV)0.450 0.437
Min–max range of strain means0.330   –   22.9   % 0.0320   –   24.6   %
Mean sample size per strain8.9   mice 10.0   mice


  ANOVA, Q-Q NORMALITY ASSESSMENT
ANOVA summary      
FactorDFSum of squaresMean sum of squaresF valuep value (Pr>F)
sex 1 4.9595 4.9595 1.0602 0.3044
strain 10 7289.3578 728.9358 155.8212 < 0.0001
sex:strain 10 209.1462 20.9146 4.4708 < 0.0001
Residuals 207 968.3513 4.678


Q-Q normality assessment based on residuals

  


  STRAIN MEANS (UNADJUSTED)
Strain Sex Mean SD N mice SEM CV Min, Max Z score
B6.129P2-Apoetm1Unc/J f 15.3 1.61   4 0.803 0.105 14.0, 17.3 0.19
B6.129P2-Apoetm1Unc/J m 17.7 1.39   5 0.622 0.0785 16.2, 19.0 0.3
B6D2F1/J f 11.8 2.33   10 0.737 0.198 8.04, 16.5 -0.36
B6D2F1/J m 12.2 0.503   5 0.225 0.0411 11.6, 12.9 -0.5
BALB/cByJ f 19.5 2.41   10 0.761 0.124 16.8, 22.9 0.85
BALB/cByJ m 20.8 2.96   10 0.937 0.143 15.8, 24.5 0.76
BALB/cJ f 16.9 2.73   10 0.865 0.161 14.0, 20.7 0.44
BALB/cJ m 20.8 2.21   10 0.699 0.106 17.5, 24.2 0.76
C3H/HeJ f 9.44 2.15   5 0.96 0.227 6.43, 11.8 -0.73
C3H/HeJ m 15.4 3.15   5 1.41 0.205 11.2, 19.8 -0.03
C57BL/6J f 15.5 2.84   30 0.519 0.183 10.0, 21.7 0.22
C57BL/6J m 13.6 1.51   15 0.389 0.111 11.4, 17.2 -0.3
CBA/J f 12.9 1.91   10 0.606 0.148 9.15, 15.9 -0.19
CBA/J m 14.9 2.3   20 0.514 0.154 9.15, 18.9 -0.11
DBA/2J f 9.61 1.16   10 0.366 0.12 7.28, 11.3 -0.71
DBA/2J m 10.1 1.3   15 0.336 0.129 7.33, 11.9 -0.81
FVB/NJ f 22.9 0.986   5 0.441 0.0431 21.8, 24.4 1.39
FVB/NJ m 24.6 1.62   10 0.514 0.066 23.1, 27.1 1.32
NOD.CB17-Prkdcscid/J f 0.33 0.135   5 0.0606 0.41 0.18, 0.54 -2.17
NOD.CB17-Prkdcscid/J m 0.032 0.0181   10 0.00573 0.567 -2.29
NOD/ShiLtJ f 20.9 1.57   15 0.406 0.0751 17.2, 23.3 1.07
NOD/ShiLtJ m 21.7 3.41   10 1.08 0.157 16.7, 28.6 0.89


  LEAST SQUARES MEANS (MODEL-ADJUSTED)
Strain Sex Mean SEM UpperCL LowerCL
B6.129P2-Apoetm1Unc/J f 15.3 1.0814 17.432 13.168
B6.129P2-Apoetm1Unc/J m 17.72 0.9673 19.627 15.813
B6D2F1/J f 11.778 0.684 13.1264 10.4296
B6D2F1/J m 12.24 0.9673 14.147 10.333
BALB/cByJ f 19.48 0.684 20.8284 18.1316
BALB/cByJ m 20.78 0.684 22.1284 19.4316
BALB/cJ f 16.95 0.684 18.2984 15.6016
BALB/cJ m 20.82 0.684 22.1684 19.4716
C3H/HeJ f 9.438 0.9673 11.345 7.531
C3H/HeJ m 15.38 0.9673 17.287 13.473
C57BL/6J f 15.5133 0.3949 16.2918 14.7348
C57BL/6J m 13.6 0.5585 14.701 12.499
CBA/J f 12.945 0.684 14.2934 11.5966
CBA/J m 14.9425 0.4836 15.896 13.989
DBA/2J f 9.61 0.684 10.9584 8.2616
DBA/2J m 10.0707 0.5585 11.1716 8.9697
FVB/NJ f 22.86 0.9673 24.767 20.953
FVB/NJ m 24.61 0.684 25.9584 23.2616
NOD.CB17-Prkdcscid/J f 0.33 0.9673 2.237 0.0
NOD.CB17-Prkdcscid/J m 0.032 0.684 1.3804 0.0
NOD/ShiLtJ f 20.9333 0.5585 22.0343 19.8324
NOD/ShiLtJ m 21.72 0.684 23.0684 20.3716


  LEAST SQUARES MEANS (MODEL-ADJUSTED), SEXES COMBINED
Strain Sex Mean SEM UpperCL LowerCL
B6.129P2-Apoetm1Unc/J both 16.51 0.7255 17.9402 15.0798
B6D2F1/J both 12.009 0.5923 13.1768 10.8412
BALB/cByJ both 20.13 0.4836 21.0835 19.1765
BALB/cJ both 18.885 0.4836 19.8385 17.9315
C3H/HeJ both 12.409 0.684 13.7574 11.0606
C57BL/6J both 14.5567 0.342 15.2309 13.8825
CBA/J both 13.9437 0.4188 14.7695 13.118
DBA/2J both 9.8403 0.4415 10.7107 8.9699
FVB/NJ both 23.735 0.5923 24.9028 22.5672
NOD.CB17-Prkdcscid/J both 0.181 0.5923 1.3488 0.0
NOD/ShiLtJ both 21.3267 0.4415 22.1971 20.4563




  GWAS USING LINEAR MIXED MODELS